Literature DB >> 8471425

Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia.

K L Smith1, M J Tisdale.   

Abstract

The effects of progressive cachexia on protein metabolism in skeletal muscle has been investigated in mice bearing the MAC16 adenocarcinoma which produces cachexia with tumour burdens of < 1% of the host weight. Weight loss was accompanied by loss of whole body nitrogen in proportion to the overall loss of body mass. Using L-[4-3H]phenylalanine to label proteins in gastrocnemius muscle, a significant depression (60%) in protein synthesis occurred in animals with a weight loss between 15 and 30% accompanied by an increase in protein degradation, which increased with increasing weight loss between 15 and 30%. Muscle degradation in vitro could be achieved by serum from cachectic animals, which appeared to contain a proteolysis-inducing factor. These results suggest that the increased degradation of skeletal muscle seen in this model of cachexia may be due to a circulating proteolysis-inducing factor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8471425      PMCID: PMC1968351          DOI: 10.1038/bjc.1993.126

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  A fluorometric method for the estimation of tyrosine in plasma and tissues.

Authors:  T P WAALKES; S UDENFRIEND
Journal:  J Lab Clin Med       Date:  1957-11

2.  Skeletal muscle metabolism in patients with malignant tumor.

Authors:  K Lundholm; A C Bylund; J Holm; T Scherstén
Journal:  Eur J Cancer       Date:  1976-06       Impact factor: 9.162

3.  Interleukin-1-induced anorexia in the rat. Influence of prostaglandins.

Authors:  M K Hellerstein; S N Meydani; M Meydani; K Wu; C A Dinarello
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

4.  Depletion of proteins of phasic and tonic muscles in tumour-bearing rats.

Authors:  C M Clark; G A Goodlad
Journal:  Eur J Cancer       Date:  1971-02       Impact factor: 9.162

5.  Arachidonic acid, prostaglandin E2 and F2 alpha influence rates of protein turnover in skeletal and cardiac muscle.

Authors:  H P Rodemann; A L Goldberg
Journal:  J Biol Chem       Date:  1982-02-25       Impact factor: 5.157

6.  The influence of tumor-bearing on protein metabolism in the rat.

Authors:  J A Norton; R Shamberger; T P Stein; G W Milne; M F Brennan
Journal:  J Surg Res       Date:  1981-05       Impact factor: 2.192

7.  Inhibition of protein synthesis in intact mammalian cells by arachidonic acid.

Authors:  E I Rotman; M A Brostrom; C O Brostrom
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

8.  Leucine kinetics in patients with benign disease, non-weight-losing cancer, and cancer cachexia: studies at the whole-body and tissue level and the response to nutritional support.

Authors:  J H Shaw; D A Humberstone; R G Douglas; J Koea
Journal:  Surgery       Date:  1991-01       Impact factor: 3.982

9.  Effects of systemic inhibition of prostaglandin production on protein metabolism in tumor-bearing rats.

Authors:  A B Strelkov; A L Fields; V E Baracos
Journal:  Am J Physiol       Date:  1989-08

10.  Bioactivity of skeletal muscle proteolysis-inducing factors in the plasma proteins from cancer patients with weight loss.

Authors:  J E Belizario; M Katz; E Chenker; I Raw
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

View more
  42 in total

Review 1.  Anorexia-Cachexia syndrome in cancer: implications of the ubiquitin-proteasome pathway.

Authors:  Carlos Camps; Vega Iranzo; Roy M Bremnes; Rafael Sirera
Journal:  Support Care Cancer       Date:  2006-07-04       Impact factor: 3.603

2.  Association of Weight Change after Colorectal Cancer Diagnosis and Outcomes in the Kaiser Permanente Northern California Population.

Authors:  Jeffrey A Meyerhardt; Candyce H Kroenke; Carla M Prado; Marilyn L Kwan; Adrienne Castillo; Erin Weltzien; Elizabeth M Cespedes Feliciano; Jingjie Xiao; Bette J Caan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-12-16       Impact factor: 4.254

Review 3.  Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cachexia.

Authors:  D Attaix; L Combaret; T Tilignac; D Taillandier
Journal:  Mol Biol Rep       Date:  1999-04       Impact factor: 2.316

Review 4.  Molecular mechanism of sarcopenia and cachexia: recent research advances.

Authors:  Kunihiro Sakuma; Wataru Aoi; Akihiko Yamaguchi
Journal:  Pflugers Arch       Date:  2017-01-19       Impact factor: 3.657

5.  Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner.

Authors:  Pippa F Cosper; Leslie A Leinwand
Journal:  Cancer Res       Date:  2010-12-16       Impact factor: 12.701

6.  Myosin heavy chain is not selectively decreased in murine cancer cachexia.

Authors:  Pippa F Cosper; Leslie A Leinwand
Journal:  Int J Cancer       Date:  2011-08-30       Impact factor: 7.396

Review 7.  Targeting cancer via ribosome biogenesis: the cachexia perspective.

Authors:  Vandré Casagrande Figueiredo; John J McCarthy
Journal:  Cell Mol Life Sci       Date:  2021-07-01       Impact factor: 9.261

8.  Expression of NF-kappaB and IkappaB proteins in skeletal muscle of gastric cancer patients.

Authors:  Mary G Rhoads; Susan C Kandarian; Fabio Pacelli; Giovan Battista Doglietto; Maurizio Bossola
Journal:  Eur J Cancer       Date:  2010-01       Impact factor: 9.162

Review 9.  Mechanisms underlying the anti-wasting effect of L-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies.

Authors:  Robert Ringseis; Janine Keller; Klaus Eder
Journal:  Eur J Nutr       Date:  2013-03-19       Impact factor: 5.614

10.  Effect of branched-chain amino acids on muscle atrophy in cancer cachexia.

Authors:  Helen L Eley; Steven T Russell; Michael J Tisdale
Journal:  Biochem J       Date:  2007-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.